BrainsWay Ltd. (BWAY)
NASDAQ: BWAY · Real-Time Price · USD
13.22
+0.12 (0.92%)
At close: Jun 27, 2025, 4:00 PM
13.07
-0.15 (-1.13%)
After-hours: Jun 27, 2025, 5:35 PM EDT
BrainsWay Employees
BrainsWay had 120 employees as of December 31, 2024. The number of employees decreased by 14 or -10.45% compared to the previous year.
Employees
120
Change (1Y)
-14
Growth (1Y)
-10.45%
Revenue / Employee
$362,142
Profits / Employee
$32,642
Market Cap
212.67M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BWAY News
- 17 days ago - BrainsWay Reports Positive Results from Multicenter Randomized Study of Accelerated Deep TMS for Major Depressive Disorder (MDD) - GlobeNewsWire
- 18 days ago - BrainsWay Announces Gold Sponsorship at the 2025 Clinical TMS Society Annual Meeting in San Diego - GlobeNewsWire
- 24 days ago - BrainsWay Announces $5 Million Minority-Stake Investment in Stella MSO, LLC - GlobeNewsWire
- 6 weeks ago - BrainsWay Ltd. (BWAY) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - BrainsWay Reports First Quarter 2025 Financial Results and Operational Highlights - GlobeNewsWire
- 3 months ago - BrainsWay Ltd. (BWAY) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - BrainsWay Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights - GlobeNewsWire
- 7 months ago - BrainsWay Reports Positive Independent Pilot Data on Accelerated Deep TMS Treatment of Alcohol Use Disorder - GlobeNewsWire